AOD-9604 + CJC-1295 + Ipamorelin (12 mg Vial) Dosage Protocol

Quickstart Highlights

This synergistic blend combines three peptides targeting body composition: AOD-9604 (hGH fragment 177–191) promotes lipolysis without raising IGF-1^[1]; CJC-1295 (GHRH analog) produces sustained GH and IGF-1 elevations^[2]; and Ipamorelin (ghrelin mimetic) selectively stimulates GH secretion without increasing cortisol or ACTH^[3]. Together, these peptides may support lean mass gains and fat reduction^[4].

Vial contents: 6 mg AOD-9604 + 3 mg CJC-1295 + 3 mg Ipamorelin (12 mg total).

Reconstitute: Add 3.0 mL bacteriostatic water → 4 mg/mL total (2 mg/mL AOD, 1 mg/mL CJC, 1 mg/mL Ip).

Typical daily range: 0.1–0.2 mL once daily (200–400 mcg AOD / 100–200 mcg CJC / 100–200 mcg Ip).

Easy measuring: At 4 mg/mL total, 1 unit = 0.01 mL = 40 mcg total (20 mcg AOD + 10 mcg CJC + 10 mcg Ip).

Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

Standard / Gradual Approach (3 mL reconstitution)

Concentration after reconstitution: 2.0 mg/mL AOD-9604 | 1.0 mg/mL CJC-1295 | 1.0 mg/mL Ipamorelin

Week	Daily Dose	Units (mL)
Week 1	200 mcg AOD / 100 mcg CJC / 100 mcg Ip	10 units (0.10 mL)
Week 2	300 mcg AOD / 150 mcg CJC / 150 mcg Ip	15 units (0.15 mL)
Weeks 3–12	400 mcg AOD / 200 mcg CJC / 200 mcg Ip	20 units (0.20 mL)

Frequency: Inject once daily subcutaneously, preferably in the morning or before bed on an empty stomach. For ≤10‑unit (≤0.10 mL) administrations during titration, consider 30‑ or 50‑unit insulin syringes for improved readability.

Reconstitution Steps

Draw 3.0 mL bacteriostatic water with a sterile syringe.

Inject slowly down the vial wall; avoid foaming.

Gently swirl/roll until dissolved (do not shake).

Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Syringe Math Reference

Using a U-100 insulin syringe (100 units = 1 mL):

1 unit (0.01 mL) = 20 mcg AOD + 10 mcg CJC + 10 mcg Ip

10 units (0.10 mL) = 200 mcg AOD + 100 mcg CJC + 100 mcg Ip

15 units (0.15 mL) = 300 mcg AOD + 150 mcg CJC + 150 mcg Ip

20 units (0.20 mL) = 400 mcg AOD + 200 mcg CJC + 200 mcg Ip

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Supplies Needed

Plan based on an 8–16 week daily protocol with gradual titration (maintenance dose: 0.20 mL/day).

Peptide Blend Vials (12 mg each):

8 weeks (~11.2 mL total): 4 vials
12 weeks (~16.8 mL total): 6 vials
16 weeks (~22.4 mL total): 8 vials

Insulin Syringes (U‑100):

Per week: 7 syringes (1/day)
8 weeks: 56 syringes
12 weeks: 84 syringes
16 weeks: 112 syringes

Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.

8 weeks (4 vials): 12 mL → 2 × 10 mL bottles
12 weeks (6 vials): 18 mL → 2 × 10 mL bottles
16 weeks (8 vials): 24 mL → 3 × 10 mL bottles

Alcohol Swabs: One for the vial stopper + one for the injection site each day.

Per week: 14 swabs (2/day)
8 weeks: 112 swabs → recommend 2 × 100‑count boxes
12 weeks: 168 swabs → recommend 2 × 100‑count boxes
16 weeks: 224 swabs → recommend 3 × 100‑count boxes

View Supplier

Protocol Overview

Concise summary of the once‑daily regimen.

Goal: Support body composition improvements through combined lipolytic and GH-stimulating mechanisms^[4]^[5].

Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).

Dose Range: 200–400 mcg AOD / 100–200 mcg CJC / 100–200 mcg Ip daily with gradual titration.

Reconstitution: 3.0 mL per 12 mg vial (4 mg/mL total concentration).

Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.

Research Disclaimer

AOD-9604 + CJC-1295 + Ipamorelin (12mg Blend Vial) Dosage Protocol